In Committee
2026 Regular Session
HB153
Log in to followAN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
Substance UseAdministrative Regulations and ProceedingsDrugs and MedicinesEffective Dates, EmergencyHealth and Medical ServicesHealth Care ProfessionalsNursesOpioidsPharmacistsPhysiciansPublic Health
Introduced: January 7, 2026
Last action: January 14, 2026
To Health Services (H)
Legislative History
Jan 7, 2026 · House
Introduced In House
Jan 7, 2026 · House
To Committee On Committees (H)
Jan 14, 2026 · House
To Health Services (H)
Primary Sponsor
Lisa.Willner@kylegislature.gov
Co-sponsors (11)
chad.aull@kylegislature.gov
steve.bratcher@kylegislature.gov
beverly.chesterburton@kylegislature.gov
Ken.Fleming@kylegislature.gov
daniel.grossberg@kylegislature.gov
vanessa.grossl@kylegislature.gov
chris.lewis@kylegislature.gov
Kimberly.Moser@kylegislature.gov
Jason.Nemes@kylegislature.gov
rachel.roarx@kylegislature.gov
sarah.stalker@kylegislature.gov
